Molecular Medicine

Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction PathwaysNovelty and Significance

Fatouma Touré, Günter Fritz, Qing Li, Vivek Rai, Gurdip Daffu, Yu Shan Zou, Rosa Rosario, Ravichandran Ramasamy, Arthur S. Alberts, Shi Fang Yan, Ann Marie Schmidt
https://doi.org/10.1161/CIRCRESAHA.111.262519
Circulation Research. 2012;110:1279-1293
Originally published May 10, 2012

Jump to

Abstract

Rationale: The mammalian diaphanous-related formin (mDia1), governs microtubule and microfilament dynamics while functioning as an effector for Rho small GTP-binding proteins during key cellular processes such as adhesion, cytokinesis, cell polarity, and morphogenesis. The cytoplasmic domain of the receptor for advanced glycation endproducts binds to the formin homology 1 domain of mDia1; mDia1 is required for receptor for advanced glycation endproducts ligand-induced cellular migration in transformed cells.

Objective: Because a key mechanism in vascular remodeling is the induction of smooth muscle cell migration, we tested the role of mDia1 in this process.

Methods and Results: We report that endothelial denudation injury to the murine femoral artery significantly upregulates mDia1 mRNA transcripts and protein in the injured vessel, particularly in vascular smooth muscle cells within the expanding neointima. Loss of mDia1 expression significantly reduces pathological neointimal expansion consequent to injury. In primary murine aortic smooth muscle cells, mDia1 is required for receptor for advanced glycation endproducts ligand-induced membrane translocation of c-Src, which leads to Rac1 activation, redox phosphorylation of AKT/glycogen synthase kinase 3β, and consequent smooth muscle cell migration.

Conclusions: We conclude that mDia1 integrates oxidative and signal transduction pathways triggered, at least in part, by receptor for advanced glycation endproducts ligands, thereby regulating pathological neointimal expansion.

Introduction

Mammalian diaphanous 1 (mDia1) is a member of the formin family, a group of multidomain proteins governing actin and microtubule remodeling.1,2 Formins are ubiquitously expressed and involved in a variety of fundamental cellular processes, such as adhesion, cytokinesis, polarity, and morphogenesis.3,4 GTP-bound Rho proteins both directly activate and may be modulated by the mDia family of formins.5,6 Release from autoinhibition allows the formin homology-2 domain to nucleate and progressively elongate linear actin filaments and to stabilize microtubules in support of polarized cell division, adhesion, and migration. Whereas the role of formins in cytoskeleton modification is well established, only limited reports are available concerning their implication in disease processes.7,8

We previously demonstrated that mDia1 binds to the intracellular domain of the receptor for advanced glycation endproducts (RAGE).9–10 mDia1 binds RAGE through its conserved poly-proline rich formin homology 1 domain. RAGE is a multiligand receptor of the immunoglobulin superfamily11 involved in a number of disease processes characterized by vascular pathology.12–17 Vascular stress leads to upregulation of RAGE ligands, including multiple members of the S100/calgranulin family such as S100B, advanced glycation endproducts, high mobility group box 1, amyloid-β peptide, and β-sheet fibrils, in the vessel wall, thereby facilitating their engagement of RAGE and induction of proinflammatory and tissue-damaging responses.17,18

The roles of RAGE and mDia1 in fundamental mechanisms governing cellular migration prompted us to test the role of mDia1 in regulation of vascular smooth muscle cell (SMC) signal transduction and migration. In vivo, we addressed these concepts by assessing the impact of mDia1 in neointimal expansion consequent to guide wire-induced endothelial denudation in a murine model. Our findings reveal novel roles for mDia1 as a key regulator of signal transduction and oxidative stress events that control SMC migration and vascular remodeling.

Methods

An expanded Methods section is provided in the online-only Data Supplement.

Animals and Induction of Vascular Injury

Male C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and then bred in house for studies. Homozygous Drf1−/− mice were generated as previously described19,20 and were backcrossed >12 generations into C57BL/6 prior to any experimentation. All procedures were approved by the Institutional Animal Care and Use Committee of Columbia University and New York University Langone Medical Center. Male mice, age 8 to 12 weeks, were anesthetized and subjected to femoral artery endothelial denudation injury as previously described.17,21 All of the surgeries were performed by a single operator naive to the genotype of the animals.

Tissue Analyses

Harvesting of vessel segments and their analysis was performed as previously described.17 Representative sections from the vessels were stained with antibodies to detect mDia1, α-smooth muscle actin or control IgG.

Western Blotting

At least 8 arteries were snapfrozen in liquid nitrogen, pooled, and stored at −80°C. Tissue samples were ground to a fine powder under liquid nitrogen and lysates subjected to SDS-PAGE and Western blotting for detection of the following antigens: RAGE, mDia1, Nox1, Nox4, p47 phox, phospho/total Akt, phospho/total glycogen synthase kinase (GSK) 3β ser 9, phospho/total ERK p44/42 mitogen activated protein kinase, and phospho/total c-Src.

Cell Culture and In Vitro Assays on Cultured SMCs

Mouse vascular SMCs were cultured from the aortas of 10-week-old male mice using a modification of the procedure of Tarvo and Barret.22 SMCs were cultured following an explant protocol in accordance with institutional guidelines. Cultures were composed of 95% SM-α-actin positivity based on immunostaining. Human recombinant S100B was prepared as previously described.23 Endotoxin was removed following previously described protocols.24

Small Interference RNA to Knockdown mDia1, Nox1, and c-Src

Small interference RNA (siRNA) duplexes against mouse mDia1, Nox1, or c-Src were synthesized by Invitrogen (Stealth RNAi). Details of sequences and electroporation into primary SMCs are found in the Online Supplement.

Cell Transfection for Dominant Negative Rac and Constitutively Active GSK3

Dominant negative constructs of Rac1 (N17, Millipore) and constitutively active GSK3β and corresponding control vectors were purified following the manufacturer's instructions and then transfected into the primary SMCs as described above (Nucleofactor). The plasmid pcDNA3-GSK3-β (S9A) was obtained from Addgene (plasmid no. 14754) and originally created by Dr. James Woodgett's laboratory.

Cell Migration

Migration in response to RAGE ligands: S100B (10 μg/mL), generously provided by Dr. Guenter Fritz, carboxymethyllysine (human serum albumin, 10 μg/mL), generously provided by Dr. Eric Boulanger, or general effectors (platelet-derived growth factor [PDGF], 50 ng/mL; epidermal growth factor [EGF], 100 ng/mL; R&D systems) was assessed with wounding assay and chemotaxis assays as described in the Online Supplement.

Reactive Oxygen Species Measurement: Assessment of Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity

Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity

Nicotinamide adenine dinucleotide phosphate oxidase (NADPH) dependent superoxide production was assessed by lucigenin-enhanced chemiluminescence as previously described.25

Dihydroethidium

Cells (1×105) were seeded and after overnight serum starvation in DMEM without red phenol, cells were preincubated with 10 μmol/L of dihydroethidium for 10 minutes then stimulated with RAGE ligands (S100B, 10 μg/mL). Fluorescence was evaluated with a fluorescent plate reader excitation/emission: 370/630 at the indicated times. Results are expressed as the difference between unstimulated and stimulated conditions.

p47phox and c-Src Translocation

Unstimulated and stimulated cells were used and manipulated following the recommendations of the manufacturer. After membranes were prepared, detergent was removed, and samples were subjected to immunoblotting for p47phox and c-Src (phospho- and total). Where indicated, immunoprecipitation experiments in SMCs were performed using rabbit polyclonal mDia1 antibody or the appropriate nonimmune IgG (Ptglab), followed by Western blotting using mouse monoclonal c-Src antibody (Cell Signaling).

Rac1 Activity

Rac1 activity was assessed with a pull-down assay using Pak1 as a specific ligand for activated Rac1 followed by SDS-PAGE electrophoresis and immunoblotting with Rac1 monoclonal antibody.

mDia1 Rescue Experiment in Drf1−/− SMCs

Plasmid pEFN.mDia1, corresponding to the murine myc-tagged derivative of mDia1 was a generous gift from Dr John Copeland (University of Ottawa).

RNA Extraction and RT-PCR

Total RNA was extracted from at least 8 vessels prepared for immunoblotting as above using the micro scale RNA isolation kit. Reverse transcription was performed following the protocol suggested by the manufacturer. The primers used are indicated in the Online Supplement.

Statistical Analysis

In all experiments, unless otherwise indicated, data are reported as the mean±SEM in at least 3 replicates per group. Data were analyzed by post hoc comparisons using 2-tailed t test, and a probability value ≤0.05 was considered significant. Statistical comparisons among groups were determined using 1-way ANOVA.

Results

mDia1 Is Upregulated in Vessels Consequent to Guide Wire Injury and Deletion of mDia1 in Mice Reduces Neointimal Expansion

To test the role of mDia1 in vascular SMC migration and signal transduction, we employed a murine model of guide wire-induced femoral artery endothelial denudation to stimulate neointimal formation.17 Wild-type (WT) C57BL/6 mice and control or sham mice were subjected to the identical procedure, the latter without guide wire injury. Pathological neointimal expansion 21 days after injury was observed by Van Gieson's elastic staining only in the guide wire-injured mice but not the sham controls (Figure 1D versus 1A, respectively). Immunostaining with anti-mDia1 IgG versus isotype control IgG revealed expression of mDia1 in all the vessels studied, consistent with the ubiquitous expression of formin proteins (Figure 1B and 1E, respectively). However, injured arteries displayed enhancement of mDia1 expression particularly in cells within the expanding neointima (Figure 1E). As vascular SMCs are a chief component of the neointima, we analyzed mDia1 expression in the vessels and found that mDia1 antigen colocalized in part with α-smooth muscle actin within the neointima (Figure 1G, 1H, and 1I). To further study regulation of mDia1 in vascular injury, we harvested femoral arteries of WT animals on day 0, 4, 10, 21, or 28 after injury and analyzed mDia1 transcripts and protein levels by quantitative real-time PCR and Western blot. mDia1 mRNA levels were significantly increased by day 4 after injury (P<0.01) compared with day 0 (Figure 1J). Consistent with this finding, compared to day 0 (no injury), mDia1 protein levels were also increased by day 4 after injury (P<0.001), and peaked at day 10 (P<0.01) (Figure 1K). An analogous pattern of expression was found for that of RAGE antigen in the vessel tissues over this time course (Figure 1L).

Figure 1.
Figure 1.

Increased expression and impact of mammalian diaphanous-related formin (mDia1) after endothelial denudation injury. Wild-type (WT), Drf1−/−, and receptor for advanced glycation endproducts (RAGE)−/− mice were subjected to femoral artery endothelial denudation or sham, and tissues analyzed at the indicated times. A and D, Assessment of neointimal expansion by Van Gieson's Elastic (EVG) staining on day 21 after injury in WT mice (A, sham, and D, injury). B, C, E, and F, Immunostaining for mDia1 or Isotype IgG control in WT mice on day 21 after injury (E, F) or sham (B, C). G–I, Colocalization studies: sections of injured vessels were stained for mDia1 and α-smooth muscle cell actin (SMA). Immunofluorescence studies revealed a colocalization of the 2 molecules in the neointima on day 21. J, qRT-PCR analysis of mDia1 expression. Sham and injured WT vessels (n=5/ group) were harvested and subjected to RNA isolation and quantitative real-time PCR analysis for detection of mDia1 transcripts. Results are expressed in mean±SEM (K, L, Western blot analysis of mDia1 and RAGE in injured vessels. WT mice (n=4 per time point and per group) were subjected to femoral artery injury. At the indicated time, arteries were retrieved and pooled for preparation of lysates. These lysates were used for Western blot analysis. Each Western blot was subjected to densitometric quantification and results are expressed as the mean±SEM of at least 3 Western blots per condition. A representative Western blot is shown. M, mDia1 expression in RAGE−/− mice subjected to femoral artery injury was detected by Western blot analysis at the indicated times. Histogram represents the mean±SEM of at least 3 Western blots per condition. A representative picture is shown. N, Quantitative analysis of RAGE expression after injury in WT and Drf1−/− mice: Lysates from n=4 mice per time point and per group were prepared as in K and L, and subjected to at least 3 independent Western blot analyses for RAGE expression. Densitometric quantification was done and data are expressed as mean±SEM. A representative Western blot is shown. O, Intima/media ratio measurement based on morphometric analysis of the vessels of WT and aged-sex-matched Drf1−/− mice (n=11/group) was performed 21 days after guide wire-induced femoral artery denudation. Representative images are shown. *P<0.05, **P<0.01, ***P<0.001.

We determined the fate of mDia1 expression in mice devoid of RAGE that were subjected to identical degrees of femoral artery injury. Interestingly, Western blotting revealed that although mDia1 was present in RAGE−/− mice vessels, its expression was not significantly altered over the same course from 0 to 28 days after guide wire injury (Figure 1). Taken together, these results revealed that mDia1 expression is upregulated in a time- and RAGE- dependent manner in injured arterial vessels.

Prompted by these observations, we sought to establish if mDia1 contributes to injury-provoked vascular remodeling. We subjected Drf1−/− mice deficient in mDia1,19 and their age- and gender-matched male WT mice to femoral artery endothelial denudation. We first analyzed RAGE expression patterns in the femoral arteries in sham and injury states and found that RAGE upregulation occurred by day 4 and day 10 in both WT and Drf1−/− mice (Figure 1N). Hence, deletion of mDia1 had no impact on RAGE expression. We performed quantitative morphometric analysis of the vessels postinjury; at 3 weeks, none of the sham-operated arteries displayed neointimal formation (data not shown), but significant neointima was observed in WT mice. compared to wt mice, the intima/media ratio was ≈4.8-fold lower in mice devoid of mDia1 (Drf1−/−), 0.77±0.4 versus 0.16±0.1, respectively; P<0.001 (Figure 1O). Consistent with this result, intimal area measurements were also highly reduced in the Drf1−/− mice and luminal area was significantly higher compared to the WT group. No significant changes were found between the 2 groups in the media area measurements or overall vessel size (internal elastic lamina and external elastic lamina) (Online Table I). These morphometric measurements are consistent with a reduced pathological inward remodeling in the Drf1−/− mice after guide wire injury.

mDia1 Deletion Blocks RAGE Induced Lamellipodia Formation and Migration in Primary Murine Aortic SMCs

Neointimal expansion in the injured vessel wall depends on a number of factors but critically on vascular SMC migration. Actin polymerization and consequent lamellipodia formation are the initial events leading to cell migration; mDia1 has been implicated in these processes. We isolated primary SMCs from WT, RAGE−/− or Drf1−/− murine aortas and analyzed mDia1 expression. Although mDia1 protein was expressed in WT cells, as well as cells devoid of RAGE, mDia1 protein was not detected in vascular SMC isolated from Drf1−/− animals (Figure 2A).

Figure 2.
Figure 2.

Mammalian diaphanous-related formin (mDia1) deletion blocks receptor for advanced glycation endproducts (RAGE) ligand-induced lamellipodia formation and vascular smooth muscle cell (SMC) migration. A, Western blot analysis of wild type (WT), RAGE−/−, and Drf1−/− cells for mDia1 and RAGE reveal that mDia1 is expressed in both WT and RAGE−/− primary murine aortic SMCs, whereas RAGE is expressed in WT and Drf1−/− cells. B, WT SMCs were stimulated with platelet derived growth factor (PDGF; 50 ng/mL) or S100B (10 μg/mL) for 30 minutes, then fixed and stained with Alexa fluor 488-Phalloidin and rabbit anti-mDia1 (secondary Rhodamine conjugated). Cells were then analyzed under an inverted fluorescent microscope (×40/×100). Representative images of lamellipodia scored are shown. C and D, Quantification of the lamellipodia formation following stimulation of SMCs with PDGF (50 ng/mL) or S100B (10 μg/mL). E and F, Transwell and wound healing scratch assay, respectively, were performed to assess SMC migration in response to RAGE ligands (S100B and carboxymethyllysine [CML], respectively 10 and 50 μg/mL) or non-RAGE ligands (PDGF and epidermal growth factor (EGF), respectively 50 and 100 ng/mL) and the effects of mDia1 deletion. All data are expressed as mean±SEM of at least 3 independent experiments. **P<0.01, ***P<0.001.

To probe the mechanisms by which mDia1 regulated vascular SMC signal transduction and migration, cells were treated with the prototypic RAGE ligand, S100B,26 to stimulate cell surface-anchored RAGE before analysis of actin content. Unstimulated cells revealed a high content of stress fibers as evidenced by phalloidin staining. Compared to unstimulated cells, incubation of WT SMCs with S100B induced disappearance of the stress fibers, change of shape with induction of cell polarity, and the appearance of cytoplasmic protrusions enriched in both F-actin and in mDia1 (lamellipodia) (Figure 2B and 2D). S100B did not induce lamellipodia formation in RAGE−/− or- Drf1−/−SMCs, suggesting that mDia1 was required for the effects of RAGE ligand S100B. In contrast, stimulation of WT, RAGE−/−, and Drf1−/− SMCs with a non-RAGE ligand, PDGF, induced lamellipodia formation comparably in SMCs from the 3 different genotypes of mice (Figure 2C and 2D). These data indicated that RAGE and mDia1 were required for S100B- but not for PDGF-stimulated lamellipodia formation.

To further evaluate the impact of mDia1 in RAGE-induced SMC migration, we performed chemotaxis experiments using Transwell migration chambers. Cells placed in the upper chamber migrated toward the chemoattractant placed in the bottom chamber (vehicle, PDGF 50 ng/mL, or S100B 10 μg/mL). WT cells demonstrated a significant chemotactic response to PDGF and S100B (Figure 2E). However, cells retrieved from Drf1−/− mice revealed significantly less S100B-induced migration, although chemotaxis in response to PDGF was not impaired in SMCs devoid of mDia1 (Figure 2E). These results were confirmed by an in vitro scratch wounding assay in cultured monolayers of SMCs, where stimulation with RAGE ligands, S100B or carboxymethyllysine-AGE human serum albumin,26–27 induced migration selectively of WT cells, but not Drf1−/− cells (Figure 2F).

EGF, which, like PDGF, is not a RAGE ligand, has been reported as a chemotactic factor requiring mDia1 cooperation in formation of lamellipodia in carcinoma cells.28 To confirm the role of mDia1 in EGF-dependent migration of SMCs, we stimulated WT SMCs with EGF, 100 ng/mL, and found that EGF induces significant migration in WT but not Drf1−/− cells (Figure 2F). These data indicate that mDia1-mediated induction of lamellipodia formation and migration of SMCs is both RAGE-dependent and RAGE-independent.

mDia1 Deletion Blocks Inhibitory Phosphorylation (Ser 9) of GSK3 β

We next sought to identify the signaling pathways regulated by mDia1 in vascular SMCs. It was previously shown in cultured fibroblasts that mDia1 modulated GSK3β serine 9 (ser 9) phosphorylation,29 and that GSK3β was implicated in SMC migration.30 We tested ser 9 GSK3β phosphorylation in injured arteries of WT mice and found a time-dependent increase in phospho-GSK3β ser 9 in WT arteries (Figure 3A). In contrast, in arteries retrieved from Drf1−/− mice, phospho-GSK3β ser 9 did not increase from baseline in response to injury over the same time course (Figure 3A). Of note, we previously demonstrated that guide wire-induced femoral artery injury resulted in activation of the mitogen activated protein kinase ERK1/2 signaling pathway in WT mice, and that this mechanism was independent of RAGE.17 Here we found that mitogen activated protein kinase ERK1/2 phosphorylation is induced equivalently at day 4 and 10 after injury in both WT and Drf1−/− animals (Figure 3B), thereby suggesting that the effects of both RAGE17 and mDia1 were likely not mediated via ERK1/2 mitogen activated protein kinases.

Figure 3.
Figure 3.

Mammalian diaphanous-related formin (mDia1) deletion blocks inhibitory phosphorylation (ser 9) of GSK3β stimulated by receptor for advanced glycation endproducts (RAGE) ligands. A and B, Glycogen synthase kinase (GSK)3β serine 9 (ser 9) phosphorylation and mitogen activated protein (MAP) kinase ERK1/2 phosphorylation were tested in lysates from wild type (WT) or age- matched Drf1−/− mice arteries after injury. Mice (n=4 per time point and per group) were subjected to femoral artery injury and followed until the indicated day. Then, arteries were retrieved and pooled for preparation of lysates. These lysates were used for Western blot analysis. Each Western blot was subjected to densitometric quantification and results are expressed as the mean±SEM of at least 3 Western blots per condition. A representative picture of these Western blots is shown. C and D, Western blot analysis of AKT/GSK3β ser 9 phosphorylation in WT and Drf1−/− primary smooth muscle cells (SMCs) stimulated with RAGE ligand S100B (10 μg/mL). Deletion of mDia1 inhibits GSK3β serine 9 and AKT phosphorylation by S100B. Results are represented as mean±SEM of 3 independent experiments. E–G, Transfection of murine mDia1 into Drf1−/− SMCs rescues AKT phosphorylation and ser 9 phosphorylation of GSK3β by S100B. In E, Western blot for mDia1 is shown in mDia1-transfected (lane 2) and mock vector control transfected (lane 3) Drf1−/− SMCs. Ln 1 represents mDia1 expression in WT SMCs. In F, mDia1- or vector-transfected SMCs were treated with S100B (10 μg/mL) and AKT (F) and ser 9 phosphorylation of GSK3β (G) was determined at the indicated time. Results are represented as mean±SEM of 3 independent experiments. (H) Western blot analysis of AKT and GSK3β ser 9 phosphorylation in WT and Drf1−/− primary SMCs stimulated with non-RAGE ligand platelet derived growth factor (PDGF) (50 ng/mL). *P<0.05, **P<0.01, ***P<0.001.

We next probed the role of mDia1 in RAGE ligand-induced GSK3β ser 9 phosphorylation in primary vascular SMCs. Deletion of mDia1 inhibited phosphorylation of AKT (a principal kinase mediating GSK3β ser 9 phosphorylation) and GSK3β (Figure 3C and D) in response to S100B stimulation. These results were confirmed by downregulation experiments in which transfection of WT cells with mDia1 siRNA significantly inhibited AKT and GSK3β ser 9 phosphorylation in response to S100B, whereas scramble-transfected cells displayed a time-dependent phosphorylation of AKT and GSK3β ser 9 (Online Figure I).

To confirm the role of mDia1 in RAGE ligand-induced GSK3β ser 9 phosphorylation, SMCs retrieved from Drf1−/− animals were transfected with full-length murine mDia1 construct to restore mDia1 expression, as assessed by Western blot (Figure 3E). Compared to vector (mock)-transfected SMCs, transfection of Drf1−/− cells with cDNA expressing mDia1 restored phosphorylation of AKT and ser 9 GSK3β in response to S100B (Figure 3F and 3G, respectively).

Lastly, we tested the effect of a non-RAGE ligand, PDGF,17 on cellular signaling. We found that phosphorylation of AKT and GSK3β was induced similarly in wild type and Drf1−/− cells in response to PDGF (Figure 3H), supporting that these effects of PDGF, as well as formation of lamellipodia (Figure 2), do not require mDia1.

GSK3β Ser 9 Inhibitory Phosphorylation Is Required for RAGE-Induced Vascular SMC Migration

Our next step was to analyze the role of RAGE in GSK3β ser 9 phosphorylation in SMC migration. We stimulated primary WT SMCs with S100B and found a dose- and time-dependent phosphorylation of GSK3β at serine 9 (Figure 4A), which did not occur in RAGE−/− SMCs (Figure 4B). To definitively implicate GSK3β phosphorylation in S100B-induced SMC migration, we transfected WT cells with a mutated form of GSK3β (constitutively active GSK3β) that is unable to be phosphorylated at serine 9. On stimulation with S100B, migration was highly significantly reduced in constitutively active GSK3β–transfected cells compared to control-transfected cells (Figure 4C). These data support the role of GSK3β ser 9 phosphorylation in S100B-RAGE-mediated SMC migration.

Figure 4.
Figure 4.

Receptor for advanced glycation endproducts (RAGE)-induced glycogen synthase kinase (GSK)3β phosphorylation is critical for smooth muscle cell (SMC) migration. A, Western blot analysis of GSK3β serine 9 phosphorylation in primary SMCs stimulated with increasing concentrations of RAGE ligand S100B for 10 minutes. B, Comparative analysis of GSK3β serine 9 (ser 9) phosphorylation in wild type (WT) and RAGE−/− SMCs stimulated with S100B (10 μg/mL). Results are presented as mean±SEM of 3 independent experiments. C, Inhibitory phosphorylation of GSK3β on ser 9 is required for RAGE-induced SMCs' migration. WT primary SMCs were transfected with an empty vector or with constitutively active GSK3β plasmid (CA-GSK3β), before analysis of S100B (10 μg/mL)-induced migration by wound healing assay. Results are represented as mean±SEM of 3 independent experiments. *P<0.05, **P<0.01, ***P<0.001.

mDia1 Deletion Blocks Reactive Oxygen Species Formation In Vivo and In Vascular SMCs

It is well established that oxidative stress is a key process implicated in vascular SMC migration and neointimal formation,31 yet; the proximal signals triggering reactive oxygen species (ROS) formation and consequent SMC migration have yet to be fully identified. To test the hypothesis that mDia1 is required for oxidative stress in vascular SMCs, we measured NADPH oxidase activity in lysates prepared from the injured arteries of WT and Drf1−/− mice. Compared to sham-operated animals, WT arteries displayed a significant increase in NADPH oxidase activity 12 hours following the injury, P<0.001, whereas no significant increases were observed in arteries retrieved from the Drf1−/− mice (Figure 5A). We next determined NADPH oxidase activity in SMCs. NADPH oxidase activity was increased by ≈2 fold in response to S100B in WT cells at 15 minutes and 30 minutes stimulation, but no significant increase was found in RAGE−/− or Drf1−/− cells (Figure 5B). We employed dihydroethidium to measure superoxide production in response to S100B stimulation in SMC, and tested the effect of siRNA-mediated reduction of mDia1 expression (Figure 5C) and deletion of mDia1. WT cells exhibited a time-dependent increase in superoxide production in response to S100B, which was maximal at 60 minutes (≈4-fold increase compared to time zero, P<0.01) (Figure 5D). S100B stimulation required RAGE, as RAGE−/− cells demonstrated no response to S100B (Figure 5D). Furthermore, SMCs transfected with mDia1 siRNA (Figure 5D) and Drf1−/− cells revealed a significant inhibition of S100B-induced generation of superoxide compared to scramble-transfected cells at 60 minutes stimulation (Figure 5D).

Figure 5.
Figure 5.

Mammalian diaphanous-related formin (mDia1) deletion blocks reactive oxygen species (ROS) formation in vivo and in vascular smooth muscle cells (SMCs). A, Wild type (WT) and Drf1−/− mice (n=3/group) were subjected to femoral artery guide wire injury. At the indicated time point, arteries were harvested and pooled prior to lysate preparation. Lysates were used for measurement of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity by chemiluminescence. Measurements were repeated in 3 independent experiments. Results are shown as plots, with a transverse bar representing the median of the data. Statistical analysis was performed on the mean+SEM. B, NADPH oxidase activity was measured by chemiluminescence in primary vascular SMCs stimulated with S100B (10 μg/mL). Results are expressed as the mean±SEM of 3 independent experiments. C, Western blot to demonstrate reduction in mDia1 expression in SMCs using small interference RNA (siRNAs) versus scramble controls. D, Measurement of superoxide production after S100B (10 μg/mL) stimulation in primary SMCs in the indicated conditions using dihydroethidium (DHE). Results are expressed as the mean±SEM of 5 independent experiments. E–G, Examination of p47phox, Nox1, and Nox4 expression. Membrane fractions were prepared from unstimulated and S100B (10 μg/mL)-stimulated WT, receptor for advanced glycation endproducts (RAGE)−/− and Drf1−/− SMCs and then tested by Western blot. Histograms represent mean±SEM of the densitometric quantification of 3 independent experiments. A representative picture is shown for each Western blot. *P<0.05, **P<0.01, ***P<0.001.

We next examined p47phox, Nox1, and Nox4, key molecules of the NADPH oxidase complex, and found that S100B stimulation of WT SMCs significantly increased the amount of p47phox at the cell membrane, whereas no translocation was found in RAGE−/− or Drf1−/− cells (Figure 5E). Further, increased expression of Nox1 was found in WT cells treated with S100B, but no increases were noted in SMCs devoid of RAGE or mDia1 (Figure 5F). In contrast, the expression of Nox4 was not modified by S100B stimulation in WT, RAGE−/− or Drf1−/− cells (Figure 5G). Note that previous studies established that upregulation of Nox1 in SMCs was accounted for by increased translation of Nox1 protein; our results are completely in line with this observation.32

mDia1, Rac1, and Nox1 Are Required for RAGE Ligand-Induced Generation of ROS and Consequent Cellular Signaling in Vascular SMCs

Rac1 is a major component of activated NADPH oxidase. To test if mDia1 impacts Rac1 activation in vascular SMCs, cells were incubated with S100B. WT but not Drf1−/− SMCs revealed activation of Rac1 at 15 minutes post-S100B stimulation (Figure 6A). Our next goal was to establish the hierarchy of vascular SMC signaling events following S100B stimulation. We first tested the relationship between RAGE induced oxidative stress and kinase phosphorylation, and examined S100B-induced GSK3 β ser 9 phosphorylation in SMCs in the presence or absence of the ROS scavenger, tyron (10 mmol/L). Incubation of SMCs with tyron inhibited S100B-stimulated GSK3β ser 9 phosphorylation (Figure 6B); similar findings were observed with N-Acetyl cysteine (25 mmol/L) (data not shown). These results suggest that ROS generation was required for RAGE-mediated ser 9 GSK3β phosphorylation.

Figure 6.
Figure 6.

Mammalian diaphanous-related formin (mDia1), Rac1, and Nox1 are involved in receptor for advanced glycation endproducts (RAGE) induced generation of ROS and consequent cellular signaling in smooth muscle cells (SMCs). A, Assessment of Rac1 activation after S100B (10 μg/mL) stimulation in wild type (WT) and Drf1−/− primary SMCs. Histogram represents mean±SEM of active Rac1 determined in 3 independent experiments. B, Tyron suppresses S100B-stimulated phosphorylation of glycogen synthase kinase (GSK)3β in SMCs. Wild type (WT) SMCs were treated with tyron (10 mmol/L) or vehicle followed by S100B (10 μg/mL) over the indicated time course. Western blotting for determination of phospho-serine 9 (ser 9)/total GSK3β was then performed in at least 3 independent experiments. Similar findings were observed with N-acetyl cysteine (25 mmol/L; data now shown). C–E, Effect of dominant negative Rac1 (DN Rac) on S100B (10 μg/mL)-stimulated superoxide production, SMCs' migration, and GSK3β ser 9 phosphorylation. Data are presented as mean±SEM of 3 independent experiments. F, Western blot indicates Nox1 expression after transfection with Nox1 small interference RNA (siRNA) versus scramble siRNA in SMCs stimulated with S100B (10 μg/mL). G and H, Effect of Nox1 downregulation in S100B (10 μg/mL)-induced superoxide production and GSK3β ser 9 phosphorylation in SMCs. *P<0.05, **P<0.01, ***P<0.001.

To explore the specific mechanisms linking RAGE and mDia1 to ROS generation, we hypothesized that Rac1 and Nox1 activation were essential for both S100B-stimulated ROS generation and kinase activation in vascular SMCs. We employed dominant negative Rac1 and Nox1 siRNA to test these concepts. Compared to cells transfected with the control vector, cells transfected with dominant negative Rac revealed significantly less generation of superoxide and migration in response to S100B (Figure 6C and D). Dominant negative Rac inhibited AKT (Online Figure II) and GSK3β ser 9 phosphorylation (Figure 6E). To confirm the role of RAGE-induced oxidative stress in GSK3β ser 9 phosphorylation, we transfected WT cells with Nox1 siRNA or scramble siRNA (Figure 6F). Downregulation of Nox1 significantly inhibited superoxide production and consequent phosphorylation of GSK3β ser 9, whereas scramble transfection had no effect on the impact of S100B (Figure 6G and 6H). Together, these data implicate Rac1 and Nox1 in RAGE ligand-induced ROS generation and signaling in SMCs.

mDia1 Is Critical for RAGE-Induced c-Src Translocation to the Membrane and Consequent Redox Signaling

It has been shown that RAGE activates c-Src kinases in SMCs33 and that c-Src kinases bind to mDia1 and act as downstream effectors of diaphanous proteins.34–35 We tested RAGE-induced c-Src phosphorylation in WT and in Drf1−/− SMCs. Analysis of total lysates found that stimulation with S100B induced phosphorylation of c-Src kinases in both WT and Drf1−/− cells (Figure 7A). However, analysis of the membrane fractions revealed that membrane translocation of phospho-c-Src in response to S100B was observed in WT cells, but not RAGE−/− or Drf1−/− SMCs (Figure 7B). To further confirm the interaction of c-Src with mDia1 we performed coimmunoprecipitation studies. Immunoprecipitation using anti-mDia1 IgG, but not nonimmune IgG, from S100B-stimulated SMC lysates resulted in immunoprecipitation of c-Src, as revealed by Western blot (Figure 7C). Anti-mDia1 antibody immunoprecipitated mDia1 by Western blot as well (data not shown).

Figure 7.
Figure 7.

Mammalian diaphanous-related formin (mDia1) regulates receptor for advanced glycation endproducts (RAGE)-induced c-Src translocation to the membrane and consequent Rac1 activation, reactive oxygen species (ROS) generation and cellular signaling in smooth muscle cells (SMCs). A, Western blot analysis of S100B induced phosphorylation of c-Src in total lysates of wild type (WT) and Drf1−/− SMCs reveals identical degrees of c-Src phosphorylation in both cell types. B, Western blot analysis of S100B (10 μg/mL)-induced c-Src translocation to the membrane in WT, RAGE−/−, and Drf1−/− primary SMCs. Membrane fractions were prepared from unstimulated and stimulated SMC and then used for Western blots for Phospho-c-Src and total c-Src. Histograms represent mean±SEM of the densitometric quantification of 3 independent experiments. A representative picture is shown for each Western blot. (C, Immunoprecipitation studies. Lysates obtained from WT SMCs were stimulated with S100B and subjected to immunoprecipitation using rabbit polyclonal anti-mDia1 IgG or isotype nonimmune control. Immunoprecipitated products were subjected to Western blot analysis of c-Src. C-Src immunoprecipitates with mDia1 antibody, but not with the isotype control. Input is Western blot for total c-Src. (D, c-Src protein expression after transfection with c-Src small interference RNA (siRNA) vs scramble siRNA. (E, c-Src is involved in RAGE induced Rac activation. Cells were transfected with c-Src siRNA prior to stimulation with S100B (10 μg/mL) and pulldown of activated rac1 was performed at the indicated time. Results are expressed as mean±SEM of 3 independent experiments; **P<0.01. F and G, Effect of c-Src downregulation in S100B (10 μg/mL)-induced superoxide production and glycogen synthase kinase (GSK)3β ser 9 phosphorylation is shown. In G, histograms represent mean±SEM of the densitometric quantification of 3 independent experiments. A representative picture is shown for each Western blot. *P<0.05, **P<0.01, ***P<0.001.

We next delineated the role of c-Src in S100B–mediated downstream events. Reduction of c-Src expression with siRNA (Figure 7D) significantly inhibited S100B-induced Rac 1 activation (Figure 7E), and ROS production in SMCs (Figure 7F), whereas scramble siRNA had no effect. Finally, down regulation of c-Src expression significantly inhibited RAGE ligand-induced AKT phosphorylation (Online Figure III) and GSK3β ser 9 phosphorylation (Figure 7G).

Taken together, these results establish a critical role for mDia1 in transducing the effects of RAGE ligands on c-Src, Rac1, and Nox1 activation in consequent phosphorylation of AKT and GSK3β ser 9, processes essential for RAGE ligand-induced vascular SMC migration. As the initial signaling events are dependent on RAGE and mDia1, these findings integrate for the first time the role of this axis in regulating oxidative and cell signaling mechanisms controlling SMC migration and neointimal formation (Figure 8).

Figure 8.
Figure 8.

Proposed mechanism of the role of mammalian diaphanous-related formin (mDia1) in receptor for advanced glycation endproducts (RAGE)-induced redox signaling, smooth muscle cell migration and neointimal expansion. Collectively, the findings in this manuscript establish a critical role for mDia1 in transducing the effects of RAGE ligands on c-Src, Rac1, and Nox1 activation in consequent phosphorylation of AKT/glycogen synthase kinase (GSK)3β ser 9, processes essential for RAGE ligand-induced vascular smooth muscle cell migration.

Discussion

Formins are effectors and modulators of Rho-GTPase signal transduction involved in regulation of actin and microtubule rearrangements during cell migration and cytokinesis.1,3 mDia1 is one of the best characterized members of this family, but only limited reports have implicated mDia1 directly in disease processes.7,8,36,37 As neointimal expansion triggered by denuding arterial injury is a well-established stress used to identify factors involved in acute vascular remodeling,21 we tested the role of mDia1 and report for the first time significant upregulation of mDia1 mRNA and protein levels in the neointima of injured arterial vessels compared to sham-treated arteries. Moreover, genetic deletion of mDia1 protected animals against neointimal hyperplasia. As invading and proliferating SMCs express mDia1 and are the main constituents of the neointima, our data link mDia1 to fundamental SMC responses to injury.

RAGE and RAGE ligands are upregulated in the vessel wall after guide wire injury, leading not only to SMC activation, migration, and proliferation, but also to extracellular matrix accumulation.17,38 Blockade of RAGE by use of soluble truncated receptor or genetic deletion significantly reduces neointimal hyperplasia in murine and rat models of injury.17,38 mDia1 is an intracellular binding partner for RAGE, critical for RAGE-induced C6 glioma cell migration and RAGE-induced Egr1 expression in hypoxic macrophages.9,10 In the latter case, we showed that hypoxia results in rapid release of RAGE ligand advanced glycation endproducts into the supernatants of cultured cells,39 hence linking hypoxia directly to activation of RAGE signaling via these advanced glycation endproducts ligands. Here we show that in injured vessels, deletion of mDia1 mimics the protective effect of RAGE blockade, suggesting that reduction of the neointimal hypertrophy in Drf1−/− mice is at least in part through blockade of the impact of RAGE. In line with this hypothesis, we found that mDia1 deletion inhibits RAGE ligand-induced signaling and cell activation in isolated SMCs.

Ligand binding to RAGE induces production of ROS largely by the NADPH oxidase system,40–41 but the proximate mechanisms involved in this process are not fully identified. Our data reveal the novel finding that mDia1 is required for RAGE-induced oxidative stress generation and consequent signaling events. Furthermore, our findings highlight seminal insights into the important role of RAGE-dependent NADPH oxidase activation as the initial key event leading to superoxide production, AKT and GSK3β serine 9 phosphorylation, and SMC migration. Activation of NADPH oxidase is an ordered multistep process, including protein phosphorylation, GTPase activation, and translocation of certain cytosolic proteins to the plasma membrane.42 Our data reveal that in mDia1 deficient cells, membrane translocation of c-Src and p47phox, activation of Rac1, and upregulation of Nox1 on RAGE ligand stimulation are inhibited, suggesting that RAGE-induced NADPH oxidase activation requires the cooperation of mDia1.

As underlying mechanisms included a possible role for mDia1 in Rac1 activation,43 we investigated the role of c-Src kinase. Src family kinases are potent activators of Rac1.44–45 They are also important effectors of the formin family of proteins.44 Additionally, recent reports highlighted the role of mDia1 in v-Src kinase membrane translocation and in c-Src mediated activation of Rac1 on EGF stimulation.46–47 In our studies, RAGE ligand-induced c-Src translocation to the membrane was defective in primary aortic SMCs isolated from Drf1−/− or RAGE-−/− mice. Our data also demonstrate key roles for c-Src in RAGE-dependent ROS generation and signaling, as siRNA-mediated reduction of c-Src expression inhibited Rac 1 activation, superoxide production and consequent AKT and GSK3β phosphorylation. These results are strengthened by previous reports suggesting a critical role for Src kinases in RAGE-dependent ROS production.33 Moreover, here we identified mDia1 as a key molecule regulating RAGE dependent c-Src translocation to the membrane and consequent redox signaling.

Previous reports have linked mDia1 and c-Src interaction to actin polymerization and cell protrusion. It was shown that mDia1 interaction with c-Src and mDia interacting protein on EGF stimulation and Vav2 activation led ultimately to Rac1 activation.46 Our results are in complete agreement with these reports and illustrate this relationship in vascular SMCs. Indeed, the potential participation of Vav2 in RAGE-induced Rac1 activation is a subject of future investigation.

It is well established that RAGE engagement potentially activates numerous signaling pathways depending on the cell type stimulated.18 Here we show that RAGE ligand S100B impacts the GSK3β phosphorylation state of serine 9. Unlike most kinases, GSK3β is constitutively active in its unphosphorylated form. Phosphorylation of GSK3β at serine 9 inhibits its activity and consequently induces glycogen synthesis, mitochondrial protection, and inhibition of the ubiquitin-proteasome system leading to cell survival and protein stability.48 Increased vascular SMC survival mediated by GSK3β ser 9 phosphorylation has been reported by Park and colleagues as a mechanism leading to neointimal expansion after balloon injury of the carotid artery in rats.30 Our data reveal that RAGE activation induces GSK3β ser 9 mediated migration of vascular SMCs, therefore suggesting that the phosphorylation status of GSK3β is important for 2 processes critically involved in neointimal expansion, SMC survival, and migration.

Importantly, we found that mDia1 deletion prevented RAGE induced phosphorylation of GSK3β and consequent SMC migration. mDia1 was previously linked to GSK3β phosphorylation during lysophosphatidic acid induced microtubule stabilization, in a manner dependent on a novel PKC isoform which was required to phosphorylate and inhibit GSK3β.29 We report that mDia1 is essential for RAGE induced c-Src translocation to the membrane and Rac1 activation. These signaling events account for RAGE-induced ROS production and consequent downstream AKT and GSK3β phosphorylation; however, a direct activation of PI3Kinase pathway by membrane bound Src cannot be excluded.

It is essential to note that although mDia1 is required for the actions of RAGE ligands and EGF on lamellipodia formation, mDia1 was not required for PDGF-mediated formation of lamellipodia nor for PDGF-stimulated phosphorylation of AKT and ser 9 GSK3β in SMCs. We previously found that knockdown of mDia1 expression in C6 glioma cells blocked carboxymethyllysine-AGE RAGE ligand-mediated cellular migration, but that reduced mDia1 expression had no effect on migration induced by a general stimulus, fetal bovine serum.10 Importantly, EGF is not a ligand for RAGE. Hence, mDia1 actions are, as expected, both RAGE-dependent and RAGE-independent. These concepts have parallels in the exquisite regulation of distinct mechanisms mediating cellular migration via RhoA versus rac1-dependent processes. It has been shown that active RhoA is present in the forward movement-provoking cellular protrusions known as membrane ruffles.49 In human umbilical vein endothelial cells, exposure to thrombin resulted in rapid activation of RhoA and inhibition of rac1; in contrast, stimulation of these cells with the bioactive phospholipid sphingosine-1-phospate resulted in very modest and delayed activation of RhoA with strong activation of rac1. In those endothelial cells, Src and rac1 were essential for recruitment of the F-actin–binding protein cortactin to sites of actin polymerization at the rim of membrane ruffles and consequent cellular migration.50 Our data link RAGE ligands to rapid activation of c-Src and rac1 in SMCs, and downstream signaling mechanisms that regulate lamellipodia formation and cellular migration in an mDia1-dependent manner. Hence, taken together, these considerations suggest defined but not unrestricted roles for mDia1 in transducing the effects of distinct mediators of signal transduction and migration cues in smooth muscle and other cell types.

Finally, our recent work has provided further support for the interaction of the cytoplasmic domain of RAGE with the formin homology 1 domain of mDia1. Shekhtman and colleagues showed that in the RAGE cytoplasmic domain, amino acids R5/Q6 were essential for the mDia1 (formin homology 1 domain) interaction; mutation of these amino acids blocked RAGE ligand-stimulated signaling, migration, and proliferation in primary murine aortic SMCs. These data, along with the published solution structure of the RAGE cytoplasmic domain with mDia1, buttress the concept that RAGE signaling requires this interaction with mDia1 to facilitate engagement of a broader range of downstream signaling effectors.51

In summary, our findings implicate for the first time the engagement of the RAGE-mDia1 axis as a critical signaling pathway for SMC function and vascular remodeling. This axis integrates a series of key events essential for aberrant neointimal expansion; we show that mDia1 is required for RAGE-induced c-Src membrane translocation and Rac1 activation, the key molecular events leading to redox phosphorylation of AKT and GSK3β and SMC migration. As deletion of mDia1 protected against aberrant vascular remodeling, blockade of RAGE-mDia1 may be a newly discovered therapeutic approach to limit pathological inward remodeling in human vascular diseases.

Sources of Funding

This work is supported by grants from “Sociéte de Néphrologie” and “Fondation Transplantation” (to F.T.), the Deutsche Forschungsgemeinschaft (FR 1488/3-1 and FR 1488/5-1, to G.F.), Van Andel Foundation (to A.S.A.) and by funds from the United States Public Health Service, HL60901 (to A.M.S.) and by funds from the JDRF (to A.M.S.).

Disclosures

None.

Acknowledgments

The authors gratefully acknowledge Dr John W. Copeland (University of Ottawa) for sharing cDNA to express murine mDia1 and Ms Latoya Woods for her expert assistance in the preparation of the manuscript.

Footnotes

  • In March 2012, the average time from submission to first decision for all original research papers submitted to Circulation Research was 13.2 days.

  • The online-only Data Supplement is available with this article at http://circres.ahajournals.org/lookup/suppl/doi:10.1161/CIRCRESAHA.111.262519/-/DC1.

  • Non-standard Abbreviations and Acronyms

    EGF
    epidermal growth factor
    GSK
    glycogen synthase kinase
    mDia1
    mammalian diaphanous-related formin
    NADPH
    nicotinamide adenine dinucleotide phosphate
    RAGE
    receptor for advanced glycation endproducts
    ROS
    reactive oxygen species
    siRNA
    small interference RNA
    SMC
    smooth muscle cell

  • Received December 8, 2011.
  • Revision received April 5, 2012.
  • Accepted April 6, 2012.

References

  1. 1.↵
    1. Baarlink C,
    2. Brandt D,
    3. Grosse R
    . SnapShot: Formins. Cell. 2010;142:172,e171.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Bartolini F,
    2. Gundersen GG
    . Formins and microtubules. Biochim Biophys Acta. 2010;1803:164–173.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Goode BL,
    2. Eck MJ
    . Mechanism and function of formins in the control of actin assembly. Annu Rev Biochem. 2007;76:593–627.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Wallar BJ,
    2. Alberts AS
    . The formins: active scaffolds that remodel the cytoskeleton. Trends Cell Biol. 2003;13:435–446.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Habas,
    2. Kato Y,
    3. He X
    . Wnt/frizzled activation of Rho regulates vertebrate gastrulation and requires a novel formin homology protein Daam1. Cell. 2001;107:843–854.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Kitzing TM,
    2. Sahadevan AS,
    3. Brandt DT,
    4. Knieling H,
    5. Hannemann S,
    6. Fackler OT,
    7. Grosshans J,
    8. Grosse R
    . Positive feedback between Dia1, LARG and RhoA regulates cell morphology and invastion. Genes Dev. 2007;21:1478–1483.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Lynch ED,
    2. Lee MK,
    3. Morrow JE,
    4. Welcsh PL,
    5. Leon PE,
    6. King MC
    . Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science. 1997;278:1315–1318.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. DeWard AD,
    2. Eisenmann KM,
    3. Matheson SF,
    4. Alberts AS
    . The role of formins in human disease. Biochim Biophys Acta. 2010;1803:226–233.
    OpenUrlPubMed
  9. 9.↵
    1. Xu Y,
    2. Toure F,
    3. Qu W,
    4. Lin L,
    5. Song F,
    6. Shen X,
    7. Rosario R,
    8. Garcia J,
    9. Schmidt AM,
    10. Yan SF
    . Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages. J Biol Chem. 2010;285:23233–23240.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Hudson BI,
    2. Kalea AZ,
    3. Del Mar Arriero M,
    4. Harja E,
    5. Boulanger E,
    6. D'Agati V,
    7. Schmidt AM
    . Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem. 2008;283:34457–34468.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Neeper M,
    2. Schmidt AM,
    3. Brett J,
    4. Yan SD,
    5. Wang F,
    6. Pan YC,
    7. Elliston K,
    8. Stern D,
    9. Shaw A
    . Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 1992;267:14998–15004.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Taguchi A,
    2. Blood DC,
    3. del Toro G,
    4. et al
    . Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 2000;405:354–360.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Yan SD,
    2. Chen X,
    3. Fu J,
    4. Chen M,
    5. Zhu H,
    6. Roher A,
    7. Slattery T,
    8. Zhao L,
    9. Nagashima M,
    10. Morser J,
    11. Migheli A,
    12. Nawroth P,
    13. Stern D,
    14. Schmidt AM
    . RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 1996;382:685–691.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Deane R,
    2. Du Yan S,
    3. Submamaryan RK,
    4. et al
    . RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003;9:907–913.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Liliensiek B,
    2. Weigand MA,
    3. Bierhaus A,
    4. et al
    . Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004;113:1641–1650.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Harja E,
    2. Bu DX,
    3. Hudson BI,
    4. et al
    . Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE−/− mice. J Clin Invest. 2008;118:183–194.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Sakaguchi T,
    2. Yan SF,
    3. Yan SD,
    4. Belov D,
    5. Rong LL,
    6. Sousa M,
    7. Andrassy M,
    8. Marso SP,
    9. Duda S,
    10. Arnold B,
    11. Liliensiek B,
    12. Nawroth PP,
    13. Stern DM,
    14. Schmidt AM,
    15. Naka Y
    . 2003. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest. 2003;111:959–972.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Schmidt AM,
    2. Yan SD,
    3. Yan SF,
    4. Stern DM
    . The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001;108:949–955.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Peng J,
    2. Kitchen SM,
    3. West RA,
    4. Sigler R,
    5. Eisenmann KM,
    6. Alberts A.S
    . Myeloproliferative defects following targeting of the Drf1 gene encoding the mammalian diaphanous related formin mDia1. Cancer Res. 2007;67:7565–7571.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Peng J,
    2. Wallar BJ,
    3. Flanders A,
    4. Swiatek PJ,
    5. Alberts AS
    . Disruption of the Diaphanous-related formin Drf1 gene encoding mDia1 reveals a role for Drf3 as an effector for Cdc42. Curr Biol. 2003;13:534–545.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Roque M,
    2. Fallon JT,
    3. Badimon JJ,
    4. Zhang WX,
    5. Taubman MB,
    6. Reis ED
    . Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20:335–342.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Tarvo P,
    2. Barret G
    . Differences in proliferation of primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels. 1980;17:110–116.
    OpenUrlPubMed
  23. 23.↵
    1. Ostendorp T,
    2. Leclerc E,
    3. Galichet A,
    4. Koch M,
    5. Demling N,
    6. Weigle B,
    7. Heizmann CW,
    8. Kroneck PM,
    9. Fritz G
    . Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 2007;26:3868–3878.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Liu S,
    2. Tobias R,
    3. McClure S,
    4. Styba G,
    5. Shi Q,
    6. Jackowski G
    . Removal of endotoxin from recombinant protein preparations. Clin Biochem. 1997;30:455–463.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Abid MR,
    2. Spokes KC,
    3. Shih SC,
    4. Aird WC
    . NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem. 2007;282:35373–35385.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Hofmann MA,
    2. Drury S,
    3. Fu C,
    4. Qu W,
    5. Taguchi A,
    6. Lu Y,
    7. Avila C,
    8. Kambham N,
    9. Bierhaus A,
    10. Nawroth P,
    11. Neurath MF,
    12. Slattery T,
    13. Beach D,
    14. McClary J,
    15. Nagashima M,
    16. Morser J,
    17. Stern D,
    18. Schmidt AM
    . RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999;97:889–901.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Kislinger TK,
    2. Fu C,
    3. Huber B,
    4. Qu W,
    5. Taguchi A,
    6. Du Yan S,
    7. Hofmann M,
    8. Yan SF,
    9. Pischetsrieder M,
    10. Stern D,
    11. Schmidt AM
    . N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation endproducts that activate cell signaling pathways and modulate gene expression. J Biol Chem. 1999;274:31740–31749.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Sarmiento C,
    2. Wang W,
    3. Dovas A,
    4. Yamaguchi H,
    5. Sidani M,
    6. El-Sibai M,
    7. Desmarais V,
    8. Holman HA,
    9. Kitchen S,
    10. Backer JM,
    11. Alberts A,
    12. Condeelis J
    . WASP family members and formin proteins coordinate regulation of cell protrusions in carcinoma cells. J Cell Biol. 2008;180:1245–1260.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Eng CH,
    2. Huckaba TM,
    3. Gundersen GG
    . The formin mDia regulates GSK3beta through novel PKCs to promote microtubule stabilization but not MTOC reorientation in migrating fibroblasts. Mol Biol Cell. 2006;17:5004–5016.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Park KW,
    2. Yang HM,
    3. Youn SW,
    4. Yang HJ,
    5. Chae IH,
    6. Oh BH,
    7. Lee MM,
    8. Park YB,
    9. Choi YS,
    10. Kim HS,
    11. Walsh K
    . Constitutively active glycogen synthase kinase-3beta gene transfer sustains apoptosis, inhibits proliferation of vascular smooth muscle cells, and reduces neointima formation after balloon injury in rats. Arterioscler Thromb Vasc Biol. 2003;23:1364–1369.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Griendling KK,
    2. Sorescu D,
    3. Lassègue B,
    4. Ushio-Fukai M
    . Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2000;20:2175–2183.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Lassegue B,
    2. Clempus RE
    . Vascular NAD(P)H oxidases: specific features, expression and regulation. Am J Physiol Regul, Integr Comp Physiol. 2003;285:R277–R297.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Reddy MA,
    2. Li SL,
    3. Sahar S,
    4. Kim YS,
    5. Xu ZG,
    6. Lanting L,
    7. Natarajan R
    . Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem. 2006;281:13685–13693.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Tominaga T,
    2. Sahai E,
    3. Chardin P,
    4. McCormick F,
    5. Courtneidge SA,
    6. Alberts AS
    . Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. Mol Cell. 2000;5:13–25.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Gasman S,
    2. Kalaidzidis Y,
    3. Zerial M
    . RhoD regulates endosome dynamics through diaphanous-related formin and Src tyrosine kinase. Nat Cell Biol. 2003;5:195–204.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Eisenmann KM,
    2. West RA,
    3. Hildebrand D,
    4. Kitchen SM,
    5. Peng J,
    6. Sigler R,
    7. Zhang J,
    8. Siminovitch KA,
    9. Alberts AS
    . T cell responses in mammalian diaphanous-related formin mDia1 knock-out mice. J Biol Chem. 2007;282:25152–25158.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Sakata D,
    2. Taniguchi H,
    3. Yasuda S,
    4. Adachi-Morishima A,
    5. Hamazaki Y,
    6. Nakayama R,
    7. Miki T,
    8. Minato N,
    9. Narumiya S
    . Impaired T lymphocyte trafficking in mice deficient in an actin-nucleating protein, mDia1. J Exp Med. 2007;204:2031–2038.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Zhou Z,
    2. Wang K,
    3. Penn MS,
    4. Marso SP,
    5. Lauer MA,
    6. Forudi F,
    7. Zhou X,
    8. Qu W,
    9. Lu Y,
    10. Stern DM,
    11. Schmidt AM,
    12. Lincoff AM,
    13. Topol EJ
    . Receptor for AGE (RAGE) mediates neointimal formation in response to injury. Circ. 2003;107:2238–2243.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Chang JS,
    2. Wendt T,
    3. Qu W,
    4. Kong L,
    5. Zou YS,
    6. Schmidt AM,
    7. Yan SF
    . Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circ Res. 2008;102:905–913.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Guo J,
    2. Ananthakrishnan R,
    3. Qu W,
    4. Lu Y,
    5. Reiniger N,
    6. Zeng S,
    7. Ma W,
    8. Rosario R,
    9. Yan SF,
    10. Ramasamy R,
    11. D'Agati V,
    12. Schmidt AM
    . RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. J Am Soc Nephrol. 2008;19:961–972.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Wautier JL,
    2. Wautier MP,
    3. Schmidt AM,
    4. Anderson GM,
    5. Hori O,
    6. Zoukourian C,
    7. Capron L,
    8. Chappey O,
    9. Yan SD,
    10. Brett J,
    11. Guillausseau PJ,
    12. Stern D
    . Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci U S A. 1994;91:7742–7746.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. El-Benna J,
    2. Dang PM,
    3. Gougerot-Pocidalo MA,
    4. Marie JC,
    5. Braut-Boucher F
    . p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med. 2009;41:217–225.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Narumiya S,
    2. Tanji M,
    3. Ishizaki T
    . Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 2009;28:65–76.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Young KG,
    2. Copeland JW
    . Formins in cell signaling. Biochim Biophys Acta. 2010;1803:183–190.
    OpenUrlPubMed
  45. 45.↵
    1. Tanji M,
    2. Ishizaki T,
    3. Ebrahimi S,
    4. Tsuboguchi Y,
    5. Sukezane T,
    6. Akagi T,
    7. Frame MC,
    8. Hashimoto N,
    9. Miyamoto S,
    10. Narumiya S
    . mDia1 targets v-Src to the cell periphery and facilitates cell transformation, tumorigenesis, and invasion. Mol Cell Biol. 2010;30:4604–4615.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Meng W,
    2. Numazaki M,
    3. Takeuchi K,
    4. Uchibori Y,
    5. Ando-Akatsuka Y,
    6. Tominaga M,
    7. Tominaga T
    . DIP (mDia interacting protein) is a key molecule regulating Rho and Rac in a Src-dependent manner. Embo J. 2004;23:760–771.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Satoh S,
    2. Tominaga T
    . mDia-interacting protein acts downstream of Rho-mDia and modifies Src activation and stress fiber formation. J Biol Chem. 2001;276:39290–39294.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Kim L,
    2. Kimmel AR
    . GSK3, a master switch regulating cell-fate specification and tumorigenesis. Curr Opin Genet Dev. 2000;10:508–14.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Pertz O,
    2. Hodgson L,
    3. Klemke RL,
    4. Hahn KM
    . Spatiotemporal dynamics of RhoA activity in migrating cells. Nature. 2006;440:1069–1072.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Vouret-Craviari V,
    2. Bourcier C,
    3. Boulter E,
    4. van Obberghen-Schilling E
    . Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells. J Cell Sci. 2002;115:2475–2484.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    1. Rai V,
    2. Maldonado AY,
    3. Burz DS,
    4. Reverdatto S,
    5. Yan SF,
    6. Schmidt AM,
    7. Shekhtman A
    . Signal transduction in receptor for advanced glycation endproducts (RAGE): solution structure of C terminal RAGE (ct-RAGE) and its binding to mDia1. J Biol Chem. 2012;287:5133–5144.
    OpenUrlAbstract/FREE Full Text

Novelty and Significance

What is Known?

  • Ligand engagement by the receptor for advanced glycation endproducts (RAGE) triggers oxidative stress in vascular smooth muscle cells.

  • Deletion of RAGE is highly protective in a murine model of femoral artery endothelial denudation injury.

  • The cytoplasmic domain of RAGE binds to the formin mDia1; in transformed cells, mDia1 is required for RAGE-activated cell migration and signaling.

What New Information Does This Article Contribute?

  • mDia1 is essential for RAGE ligand-mediated generation of oxidative stress.

  • Expression of the formin mDia1 is elevated in the arterial tissue of wild-type, but not RAGE-null, mice after femoral artery endothelial denudation injury.

  • mDia1 is required for RAGE ligand-stimulated generation of Rac and lamellipodia, the recruitment of c-Src to the plasma membrane, activation of Akt and GSK-3β serine 9, and the in vivo migration of vascular smooth muscle cells following femoral artery endothelial denudation injury.

The transmembrane RAGE molecule lacks intrinsic signaling activity despite strong evidence for its ability to induce tyrosine signaling and cell migration in response to stress. Previous studies identified the formin mDia1 as a binding partner that interacts directly with the cytoplasmic tail of RAGE. mDia1 is a canonical Rho GTPase member of the diaphanous-related formin family. mDia1 generates linear actin filaments and stabilizes microtubule dynamics and is known to dock with Src family nonreceptor tyrosine kinases. Using genetically deficient mice or cells lacking either RAGE or mDia1, we tested the hypothesis that mDia1 is a key intermediate in RAGE signaling. We report that injury to the femoral artery significantly upregulates mDia1 gene and protein expression and is RAGE-dependent. Loss of mDia1 expression significantly impairs pathological neointimal expansion consequent to injury that is known to activate RAGE. In primary murine aortic smooth muscle cells, mDia1 is required for RAGE ligand-induced membrane translocation of c-Src, Rac1 activation, redox phosphorylation of AKT and GSK3β, and migration. Hence, for the first time we have illustrated key roles for mDia1 in smooth muscle cell migration and signal transduction. Taken together, these data illuminate a novel RAGE-mDia1 signaling axis that mediates pathobiological neointimal formation in the vasculature in response to injury.

View Abstract

This Issue

Jump to

Article Tools

Share this Article

  • Email
  • Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction PathwaysNovelty and Significance
    Fatouma Touré, Günter Fritz, Qing Li, Vivek Rai, Gurdip Daffu, Yu Shan Zou, Rosa Rosario, Ravichandran Ramasamy, Arthur S. Alberts, Shi Fang Yan and Ann Marie Schmidt
    Circulation Research. 2012;110:1279-1293, originally published May 10, 2012
    https://doi.org/10.1161/CIRCRESAHA.111.262519
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects